SynthesisBMC musculoskeletal disorders2026
Prevalence of hip and knee osteoarthritis in Europe: a systematic review and meta-analysis.
Synthesis in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Knee Osteoarthritis and Metabolic Disorders: Practical Aspects from Primary Healthcare.Journal of clinical medicine · 2026Article
- Effectiveness of Diosmin, Cumarin and Arbutin in Reducing Edema and Pain After Hip or Knee Arthroplasty.Journal of clinical medicine · 2026Article
- Pain Modulation, Inflammation-Regulatory Mechanisms, and Translational Boundaries of Evidence for Acupuncture-Related Therapies in Knee Osteoarthritis: A Structured Narrative Review.Journal of pain research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOsteoarthritis (OA) is a leading cause of pain and disability worldwide, with the hip and knee being the most commonly affected major joints. These forms of OA contribute substantially to individual suffering, reduced quality of life, and increased healthcare costs. While global estimates of OA prevalence are available, there is a paucity of reliable, region-specific data for Europe. This systematic review aims to address the following questions: (1) What is the prevalence of hip and knee OA in Europe? (2) How does this prevalence vary across different regions? (3) How does the reported prevalence differ depending on the diagnostic methods used?
methodsA systematic literature search was conducted in PubMed and Embase for studies published between January 1, 2000, and November 14, 2024. Study quality and risk of bias were assessed independently using the Joanna Briggs Institute (JBI) checklist. Pooled prevalence estimates were calculated using random-effects meta-analysis, and subgroup analyses were performed by diagnostic method and geographic region. The review was prospectively registered with PROSPERO (CRD42022302976) and conducted in accordance with PRISMA guidelines.
resultsTwenty nine studies were included, comprising data from 6,767,340 individuals for hip OA and 6,805,777 for knee OA. The pooled prevalence of hip OA in Europe was estimated at 6% (95% CI: 3-9%), and for knee OA, 10% (95% CI: 7-14%). Subgroup analysis by diagnostic method revealed that prevalence was highest for hip OA when using Kellgren-Lawrence grade ≥ 2 (11.5%, 95% CI: 5.0-24.5%) and for knee OA when using American College of Rheumatology (ACR) criteria (14.5%, 95% CI: 7.6-25.9%). Subgroup analysis by European region showed that hip OA prevalence ranged from 2% in Eastern Europe to 7% in Southern Europe, while knee OA ranged from 7% in Northern Europe to 19% in Eastern Europe.
conclusionHip and knee OA are common in Europe, though prevalence varies widely across studies and diagnostic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.